Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Danish pharmaceutical company Lundbeck has announced a $2.6 billion deal to acquire Longboard Pharmaceuticals, gaining access to their epilepsy drug currently in late-stage development. The FDA's accelerated approval pathway has seen withdrawals and failures recently, despite having helped bring nearly 300 new drugs to market since 1992.In other news, Novo Nordisk has...